Form 4 for LXEO Lexeo Therapeutics, Inc.
Accepted 2025-08-20 00:00:00 ET · period of report 2025-08-18 · accession 0001415889-25-022479 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-20 | 2025-08-18 | LXEO | Otero Jose Manuel | Chief Technical Off | S - Sale | $4.67 | -2,848 | 60.4K | -5% | -$13.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-18 | S | D | 2,848 | $4.67 | 60,372 | D | — | — | (F2) Includes 49,687 RSUs. |